Mediaboss Marketing

Leclanch SA / Key word(s): Miscellaneous

07.08.2012 07:00

Release of an ad hoc announcement pursuant to Art. 53 KR =--------------------------------------------------------------------------

Not for release, publication or distribution in the United States of America, Canada, Japan or Australia

Leclanch

Press Release

Leclanch raises additional gross proceeds of CHF 3.9 million

Yverdon-les-Bains, August 7, 2012 - Leclanch S.A. (SIX Swiss Exchange : LECN), specialized in the production of large-format lithium-ion cells and energy storage solutions, announced today the exercise of 492,114 warrants (SIX Swiss Exchange : LECNW) at the end of the warrant exercise period, which closed on August 6, 2012. As a result of the exercise of these warrants, 246,057 new registered shares were issued, leading to gross proceeds of CHF 3.9 million.

'We would like to warmly thank our shareholders for their continuing support and confidence. These additional funds will allow us to increase our operational flexibility as we are bringing to the market high performance energy storage solutions,' said Dr. Ulrich Ehmes, CEO of Leclanch S.A. 'With the recent installation of our new production unit in Willsttt, one of the few of its kind in Europe, we are able to address the increasing need for efficient storage solutions both for domestic and industrial clients.'

About Leclanch

Excerpt from:
Bestellen Sie den kostenlosen Newsletter von 4investors:

Not for release, publication or distribution in the United States of America, Canada, Japan or Australia

Leclanch

Press Release

Leclanch raises additional gross proceeds of CHF 3.9 million

Yverdon-les-Bains, August 7, 2012 - Leclanch S.A. (SIX Swiss Exchange : LECN), specialized in the production of large-format lithium-ion cells and energy storage solutions, announced today theexercise of 492,114 warrants (SIX Swiss Exchange : LECNW) at the end of the warrant exercise period, which closed on August 6, 2012. As a result of the exercise of these warrants, 246,057 new registered shares were issued, leading to gross proceeds of CHF 3.9 million.

We would like to warmly thank our shareholders for their continuing support and confidence. These additional funds will allow us to increase our operational flexibility as we are bringing to the market high performance energy storage solutions, said Dr. Ulrich Ehmes, CEO of Leclanch S.A. With the recent installation of our new production unit in Willsttt, one of the few of its kind in Europe, we are able to address the increasing need for efficient storage solutions both for domestic and industrial clients.

About Leclanch

Leclanch specializes in the production of tailor-made energy storage solutions. Leclanchs strategy is to expand its position as one of the leading lithium-ion cell producers and solution providers for renewable energy storage systems in Europe. Its initial strategic priorities are stationary home electrical energy storage applications and expansion into the stationary industrial and grid electricity storage markets. Through participation in research consortia focusing on off-road and automotive applications, Leclanch is positioned to take advantage of new market opportunities.

Through a unique, patented ceramic separator technology and focus on lithium-titanate technology, Leclanch manufactures large-format lithium-ion cells, optimized for safety and cycle-life, in a fully automated production process. At the end of the second quarter 2012, Leclanch started operations of its first production line with an installed annual capacity of up to 76 MWh in lithium-titanate cells.

Leclanch was founded in 1909 in Yverdon-les-Bains. Through the integration of a spin-off from the Fraunhofer-Gesellschaft in 2006, the company evolved from a traditional battery manufacturer to become a leading developer and manufacturer of lithium-ion cells in Europe. Leclanch currently employs 120 staff and is listed on the SIX Swiss Exchange (LECN). The company has its headquarters in Yverdon-les-Bains (Switzerland) and production facilities in Willsttt (Germany).

Here is the original post:
DGAP-Adhoc: Leclanché raises additional gross proceeds of CHF 3.9 million

BIRMINGHAM, Alabama -- Several legislators, who were called upon today by a group to repudiate another legislator's use of the word "rogue" to describe two other colleagues, said they did not take the comment to be negative when they heard it.

"Ms. Todd is entitled to her opinions," said State Sen. Linda Coleman.

The Committee to Develop Birmingham this morning held a press conference to call upon five state legislators to repudiate a recent comment by Alabama State Rep. Patricia Todd, who is white, that referred to two African American legislators from Jefferson County as "rogue" delegation members.

Todd, who is white, used the word in a comment referring to State Reps. John Rogers and Mary Moore at a July 30 meeting regarding the state takeover of Birmingham city schools. Others legislators in that meeting were Sens. Linda Coleman and Priscilla Dunn and Reps. Merika Coleman, Rod Scott, and Juandalynn Givan, who also are African American.

Todd today apologized if the use of the word rogue offended anyone. But she said she meant it as a description of someone who goes outside the consensus of the group, which in that case was the group of legislators. "I meant it in terms of their behavior ... my statement was an adjective, not a noun," she said.

Todd had made the "rogue" comment in reference to previous comments by Rogers and Moore. ''We have two rogue members of the delegation who, unfortunately, people think are speaking on behalf of the entire delegation. We all get lumped together,'' Todd had said.

Scott said that if Todd said "rogue" then he doesn't think he took it as a negative. "If I heard I probably took it in the way she (Todd) interpreted it," he said.

However, Scott said, he would never call a colleague a rogue representative.

Givan said she didn't think Todd meant the word "rogue" in the way some have interpreted it.

She said she believe that Todd was saying what she and other legislators have all said "that we don't all speak for each other."

Follow this link:
Alabama State Rep. Patricia Todd's use of the word "rogue" not viewed as negative by a few colleagues

Julia Allison, one of the Web's biggest self-promoters, explains how to define your brand before others do it for you.

Flickr/eschipul

Julia Allison

I was convinced that trying to build a personal brand, especially for the average small-business owner, is a waste of time. And I was admittedly kinda smug about it.

Then Julia Allison put me solidly in my place--in the nicest possible way, mind you.

Here's another in my series in which I pick a topic, connect with someone smarter than me, and we discuss. (There's a list of previous installments at the end of this article.)

This time, I talked to Julia Allison, Elle columnist, speaker on all things branding related, and star of the Bravo series Miss Advised. She was also profiled in Wired a few years ago for her personal branding savvy.

Jeff: If I say the average small-business owner shouldn't worry about personal branding, what would you say?

Julia: I would start by laughing.

Continue reading here:
One Word That Defines a Great Personal Brand

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS

Press Release

4SC AG further strengthens Supervisory Board with experienced managers from the pharmaceutical industry

Planegg-Martinsried, Germany, 6 August, 2012 - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, today announced the appointment of Dr Irina Antonijevic and Mr Klaus Khn to the companys Supervisory Board.

In a by-election at todays Annual General Meeting of 4SC AG, Dr Antonijevic and Mr Khn were elected to the Supervisory Board for the remaining term of Dr Jrg Neermann and Mr Gnter Frankenne, who have stepped down from the Supervisory Board. The terms of office will run until the end of the Annual General Meeting that resolves on formally approving the actions of the Supervisory Board for financial year 2012.

Dr Antonijevic, Director Clinical Research at US pharmaceutical company Sanofi, has many years of international experience in clinical drug development and extensive expertise gained in executive positions both in the pharmaceutical industry and in medical research in a university environment.

Klaus Khn, former Chief Financial Officer of Bayer AG (2002 to 2010), has more than 30 years of experience in executive positions primarily in the chemical and pharmaceutical industry with a focus on finance and accounting.

The shareholders of 4SC AG also approved all of the resolutions proposed to the Annual General Meeting by the Management Board and the Supervisory Board with the required majority, including the following items:

- Resolution on the approval of the remuneration system for members of the Management Board;

- Approval of a control and profit transfer agreement between 4SC AG and 4SC Discovery GmbH;

View post:
DGAP-News: Press Release: 4SC AG further strengthens Supervisory Board with experienced managers from the ...